5-Amino-1MQ × nurapeptide.com — Lab Test, June 2026
COA 2606110438 matches freedomdiagnosticstesting.com's public record. So this test doesn't rest on our review alone — the lab confirms it too.
Nura2606110438Test results
This is a purity and identity analysis. Sterility, endotoxins, and heavy metals were not screened — a high purity figure says nothing about those.
About this test
Label 10 mg · Lab measured 11.57 mg
116% of label, basis not stated — shown as printed. Reconstituted with 2 mL, a 50-unit draw holds 2.9 mg using the measured mass, against 2.5 mg on the label — 16% more.
One vial from this lot was weighed by the laboratory, not yours. This page reports what the certificate says; it does not recommend a dose.
| Report number | 2606110438 |
|---|---|
| Portal lookup | ✓ Lab-verified |
| Checked | 30 Jul 2026date taken from the record, not from a logged check |
| Checked by | Peptigrity staff, against the lab's portal |
| PDF vs portal | freedomdiagnosticstesting.com's portal shows validity only |
| Weight | Counts as one lab test |
Independent HPLC purity analysis of 5-Amino-1MQ from nurapeptide.com, performed by freedomdiagnosticstesting.com on June 14, 2026. Reported purity: 99.85%. Net content: 11.57 mg against 10 mg labeled (116% of label). Tested content exceeds the labeled amount by 16%. Endotoxins: Pass (≤0.05 EU/mL). Batch 5AM10-062026-1. Sample source: shop-provided. Certificate of analysis attached.
Certificate of analysis
Other lots of 5-Amino-1MQ from nurapeptide.com
| Lot | Tested | Lab | Purity | vs label | Status |
|---|---|---|---|---|---|
| 5AM50-062026-1 | 25 Jun 2026 | freedomdiagnosticstesting.com | 99.88% | 107% | ✓ Lab-verified |
| 5AMI-04926 | 9 Apr 2026 | freedomdiagnosticstesting.com | 99.705% | 118% | ✓ Lab-verified |
Batches this shop has published a certificate for, newest first. A lot whose printed value cannot identify a batch is not listed.
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion